glp 1 agonist effects GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP1 Receptor Agonists—Effects beyond Obesity

10.1007/s12020-019-01891-3 93 SmitsM

Most GLP-1s are started at a low dose and then slowly increased to minimize potential side effects

For Wharton, having these pills as treatment options is a matter of accessibility

Cash-Pay Patients If paying out-of-pocket regardless of brand: Zepbound: $1,069/month Compounded tirzepatide: $349/month Save $720/month ($8,640/year) with compounded option Availability Considerations: Shortage Status: Both Mounjaro and Zepbound have experienced shortages: High demand exceeding manufacturing capacity No guarantee either is available at your pharmacy May need to call multiple pharmacies Wait times of weeks to months during shortages Supply is improving as of late 2025, but intermittent shortages still occur